 Citigroup Inc. grew its holdings in Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 90.1 during the fourth quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The firm owned 2,251 shares of the companys stock after purchasing an additional 1,067 shares during the period. Citigroup Inc.s holdings in Crinetics Pharmaceuticals ... 